Cgenetix
Develops liquid-biopsy diagnostics for clinicians monitoring organ damage in transplant patients
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Cgenetix
CGenetix is developing molecular diagnostic tools based on liquid biopsy, epigenetic analysis and digital PCR to assess organ damage and graft function. Its stated clinical applications include kidney and lung transplantation.
The company works with clinicians and healthcare professionals; its team combines expertise in molecular biology, bioinformatics, clinical data analysis and transplantation medicine.
CGenetix was founded in 2022 and is based in Paris, France. The company has a strategic committee and collaborates with partners in the healthcare and life-sciences ecosystem.
Product: Developing liquid-biopsy molecular diagnostic tests using epigenetic analysis and digital PCR for transplant monitoring.
Jobs at Cgenetix
More biotech & pharma companies
Chelatec
Preclinical radiolabeling and drug-development research services for pharmaceutical and biotechnology companiesNew on EvolcCherry Biotech
Develops organoid culture systems and preclinical testing services for drug developers and life-science researchersNew on EvolcChiesi
Pharmaceutical company developing and marketing medicines for respiratory, neonatal, transplant and rare diseases in FranceNew on EvolcChromagar
Chromogenic culture media for clinical, food, water-testing and veterinary microbiology laboratoriesNew on EvolcCilcare
Preclinical auditory research and drug-development services for pharmaceutical, biotech and medical-device partnersNew on EvolcClinisciences
Life-science research reagents and custom laboratory services for researchers, academic labs and biotech and pharmaceutical companiesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.